Daniela Andriuta Selected Research

hexamethylpropyleneamine oxime

4/2018

Inferior Parietal Cortex Hypoperfusion is the Most Specific Imaging Marker for AD Patients With Positive CSF Biomarker Assays in a Memory Clinic in France.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Andriuta Research Topics

Disease

2	COVID-19 01/2022 - 10/2020
2	Cognitive Dysfunction 04/2018 - 01/2016
2	Alzheimer Disease (Alzheimer's Disease) 04/2018 - 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Disease Progression 01/2022
1	Headache (Headaches) 04/2021
1	Hypothermia 04/2021
1	Parkinson Disease (Parkinson's Disease) 04/2021
1	Shapiro syndrome 04/2021
1	Brain Diseases (Brain Disorder) 10/2020
1	Epilepsia Partialis Continua 08/2015

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 04/2018 - 01/2016
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Clonidine (ST 155)FDA LinkGeneric 04/2021
1	AntibodiesIBA 10/2020
1	hexamethylpropyleneamine oximeIBA 04/2018

Therapy/Procedure

1	Therapeutics 04/2021
1	Stem Cell Transplantation 08/2015